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The antimicrobial peptide esculentin 1–21 (Esc 1–21) is a shorter synthetic version of the 46-residue peptide occurring in the Rana esculenta
skin secretion. Here we propose an integrated proteomic and transcriptomic approach to interpret the biological effects of this peptide on
Saccharomyces cerevisiae. We further investigated the response to this peptide by correlating the results of the transcriptome and proteome
analysis with phenotypic effects. The results show that S. cerevisiae adapts to Esc 1–21 using the High Osmolarity Glycerol (HOG) pathway
involved in osmotic tolerance and cell wall maintenance. Comparative proteomics reveals that Esc 1–21 causes downregulation of enzymes of the
lower glycolytic pathway and in genes involved in spindle body formation and remodelling of cell-wall synthesis. Moreover the peptide induces
downexpression of protein actin within 45 min and cells pre-treated with peptide show less sensitivity to osmotic stress and increased sensitivity to
heat shock stress. The results obtained with the two different methodologies are in agreement at the cellular process levels. A combined approach
may help elucidate the main aspects related to the effects of this peptide on the eukaryotic cell. The employment of different technologies may
reveal the potential and limitations of each adapted approach in a prospective application for drug screening.
© 2007 Elsevier B.V. All rights reserved.Keywords: S. cerevisiae; Systems biology; Proteomic; Transcriptomic; Antimicrobial peptide1. Introduction
Some multicellular organisms in the phylogenetic tree
produce a variety of different compounds as an early protective
response against bacteria, fungi and viruses, which constitutes
the so-called innate immune system. In addition, higher
eukaryotes have evolved a sophisticated defense system com-
prising a complex network of humoral and cellular responses,
called “adaptive immunity” [1]. Innate immunity was discovered
in the early 1980s and gene-encoded antimicrobial peptides
(AMPs) represent its major component in all living organisms,
where they act as a first barrier against a broad range of invading⁎ Corresponding author. Fax: +39 055 459 8905.
E-mail address: modesti@scibio.unifi.it (A. Modesti).
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1570-9639/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbapap.2007.04.006pathogens [2,3]. Accordingly, they are located at the anatomical
sites primarily involved in contact with microorganisms, such as
mucosal, epithelial or phagocytic cells [4–6]. Although AMPs
differ significantly in their sequences, most of them share some
features, such as a high positive charge and a potential to adopt
an amphipathic α-helix and/or β-sheet structures upon interac-
tion with membranes [7]. To date, there is compelling evidence
that a common step in the microbial killing mechanism is the
electrostatic interaction of AMPs with the negatively charged
cell membrane followed by its permeation/disruption [8] or with
the actin cables of the cytoskeleton [9]. The amphibian skin
secretions constitutes one of the richest sources of AMPs that are
synthesized and stored within granules of holocrine-type serous
glands and released upon stimulation [10,11]. Among the skin
secretions of Rana esculenta, the esculentin-1 family of pep-
tides, (containing 46-amino acids with a C-terminal hepta-
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potent, being active against both Gram-positive and Gram-
negative bacteria, yeasts and filamentous fungi, with negligible
effects on eukaryotic cell membranes [12]. It has already been
reported that the antimicrobial activity of the esculentin-1a is
located in its N-terminal portion and that at least the first 18
residues are required for its antimicrobial properties [13].
Therefore, to better investigate the antifungal activity of
esculentin, we synthesized a shorter analogue containing 21
amino acids and tested it against Saccharomyces cerevisiae.
This peptide was named esculentin-1a (1–21) (Esc 1–21), since
it shares the first 20 residues with the natural esculentin-1a.
Differently from Esc 1–18, Esc 1–21 carries the substitution Leu
11 Ile and three additional C-terminal residues (Leu–Lys–Gly)
which give it a higher net positive charge and a length which is
optimal, for an alpha-helical peptide, to span the phospholipid
bilayer (Table 1). During the last few years, a considerable
number of studies have been carried out with AMPs on bacteria,
fungi, viruses and tumor cells, in an attempt to understand the
parameters responsible for their mechanism of action. Never-
theless, reports on the gene and protein expression profile of
cells exposed to a sub-lethal peptide concentration are still very
scarce. In this study we used S. cerevisiae as a model to study the
mechanisms of action of Esc 1–21 using an integrated approach.
The choice of yeast as a model is based on several considera-
tions: it is one of the key model genetic organisms and a great
deal is known about its molecular biology, cell biology,
metabolism and physiology. More generally, it has been
demonstrated that about 900 genes are part of common
environmental stress response (ESR) to several unrelated
environmental challenges [14]. S. cerevisiae has also been
extensively used for whole genome approaches investigating the
effect of drugs on the transcriptome [15]. Yeast has also been the
model of choice for proteomic studies using 2D gels and mass
spectrometry to characterize the response to different stressors
[16] or to the expression of specific genes [17]. Nevertheless
studies investigating the effects of drugs on the proteome and/or
both on the proteome and the transcriptome have not been
conduced in an integrated manner.
Here we describe the effect of Esc 1–21 on yeast cell biology
by measuring cell viability and growth rate. At the same time we
elucidate the genomic determinants of these effects, through
analysis of the proteome and transcriptome. The results obtained
show that Esc 1–21 slows down yeast growth without causing
cell death by affecting the expression of specific genes and
therefore, by modulating the synthesis of many proteins
involved in rerouting the metabolism of cell membranes andTable 1





Amino acid sequences and net charge of esculentin-1a (natural peptide), esculenti
esculentin-1a.
a Amino acid substitutions are boldfaced.cell bioenergetics. Our results demonstrate that 2-DE electro-
phoresis combined with mass spectrometry and gene expression
provide a useful approach to profiling antimicrobial peptides
according to their protein and gene expression patterns.
2. Materials and methods
2.1. Peptide and yeast strain and media
Synthetic Esc1–21 were purchased from SYNT:EM (Nimes, France). The
peptide solution was prepared in 20% ethanol at a final concentration of 1.2 mM.
The yeast strain used in this study was S. cerevisiae W303-1A (MATa, leu2-
3,112ura3-1 trp1-92 his3-11, 15 ade2-1 can1-100, GAL SUC mal). The growth
medium used was YEPD (yeast extract, 1%; peptone, 2%; dextrose, 2%). All
media and reagents were from Merck.
2.2. Measurement of growth inhibition activity
The antifungal activity of the peptide was assayed by microspectrophoto-
metry of liquid culture growth in 96-well microtiter plates for 24 h by measuring
optical density at 640 nm with a Victor high throughput microplate spectro-
photometer equipped with a 96-well plate reader (Perkin Elmer) [18]. Briefly
exponential-phase cells were harvested and suspended in 0.2 ml of liquid YEPD
(0.1×107 cells/ml) containing 10, 25, 50 μM of Esc 1–21 or 0% v/v, 0.4% v/v,
0.8% v/v of ethanol as control.
To assess the viability of yeast cells, exponentially growing W303-1A cells
were diluted to 0.8×107 cells/ml in liquid YEPD medium containing 25, 50 and
100 μM of Esc 1–21. After incubation for 0, 3, 6 and 9 h at 30 °C, the cells were
plated on YEPD without peptide for 2 days at 30 °C.
2.3. Effect of hyperosmotic or heat stresses on peptide sensitivity
To analyze the effect of hyperosmotic stress on Esc 1–21 sensitivity
0.8×107 cells/ml were pre-treated in liquid YEPD with different concentrations
of peptide (25, 50, 100 μM) for 0 and 3h and plated after appropriate dilutions on
YEPD agar and YEPD agar supplemented with 0.6 M sorbitol and without
peptide for 2 days at 30 °C. Osmotic tolerance was expressed as the percentage
of cells able to grow on YEPD agar supplemented with 0.6 M sorbitol compared
to those growing on YEPD agar.
To analyze the effect of heat stress on Esc 1–21 sensitivity, 0.8×107 cells/ml
were treated with different concentrations of peptide (25, 50, 100 μM) for 0 and
3 h and after incubation were divided into two aliquots. An aliquot was plated on
YEPD agar as a control; another aliquot was heated for 20 min at 52 °C. After
cooling, cells were spread onYEPD agar without peptide. Colonies were counted
after 2 days at 30 °C. Heat stress resistance is expressed as the percentage of cells
able to give rise to colonies after heating compared to the control.
2.4. Preparation of yeast cell extracts for 2D electrophoresis
W303-1A yeast cells (0.8×107 cells/ml) were treated with 50 μM Esc1–21
in liquid YEPD and incubated at 30 °C with shaking for 45 (T1) and 90 (T2)
min. Treated and untreated cells were harvested by centrifugation at room
temperature. The pellet was washed twice in water and resuspended in 8 M urea,
4% (w/v) CHAPS and 10 mM DTT. Cells were broken with glass beads in a
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assay (Pierce Biotechnology, Inc).
Two-dimensional electrophoresis—2-DE was performed using the Immobi-
line polyacrylamide system as described in [17]. Briefly, 60 μg (analytical) or
500 μg (preparative) of protein sample were applied on a commercial non-linear
immobilized pH gradient from pH 3 to pH 10, of 18 cm length (Amersham
Biosciences, Uppsala, Sweden ). Isoelectric focusing was carried out on the
Ettan™ IPG phor™ system (Amersham Biosciences). IPG strips were
rehydrated in 350 μL of lysis buffer and 0.2% (v/v) carrier ampholyte for 1 h
at 0 V and for 8 h at 30 V, at 16 °C. The strips were focused according to the
following electrical conditions at 16 °C : 200 V for 1 h, from 300 to 3500 V in
30 min, 3500 V for 3 h, from 3500 to 8000 V in 30 min, and 8000 until a total of
80,000 V/h was reached. Following IEF separation, the strips were equilibrated
with 10ml of a solution containing 50mMTris–HCl pH 6.8, 6M urea, 30% (v/v)
glycerol, 2% (w/v) SDS and 2% (w/v) DTE for 12 min and with 10 ml of a
solution containing 50 mM Tris–HCl pH 6.8, 6 M urea, 30% (v/v) glycerol,
2% (w/v) SDS, 2.5% (w/v) iodoacetamide and a trace of bromophenol blue
for 5 min. The IPG strips were then placed on 12% SDS –PAGE gels
(18 cm×20 cm×1.5 mM) and overlaid with a solution of 0.5% (w/v) agarose.
The second-dimensional SDS-PAGE was carried out at 40 mA per gel
constant current, at 10 °C, until the dye front reached the bottom of the gel.
Analytical gels were stained with ammoniacal silver nitrate as previously
described [19]. The MS-preparative gels were stained according to a silver
staining protocol compatible with MS [20]. Volume ratio of the spot observed
in the different 2-DE patterns was obtained using the differential analysis tool
of Melanie 4 software (GeneBio, Geneva, Switzerland). For the proteomics
experiments we performed three independent biological repetitions and three
technical replicates of the 2-DE gels for each experimental condition.
2.5. Protein identification by peptide mass fingerprinting
(MALDI-ToF MS)
Protein spots of interest were manually cut out of the gel and destained in
30 mM potassium ferricyanide/100 mM sodium thiosulfate/H2O solution (1:1:2,
by vol.). Gel pieces were then washed 6 times with deionized water, equilibrated
with 200 mM ammonium bicarbonate for 20 min, washed with deionized water,
dehydrated twice with acetonitrile for 20 min and in-gel digested with trypsin
(Trypsin Gold, mass spectrometry grade, Promega) according to the
manufacturer’s protocol. Peptides were extracted from the gel with 50%
acetonitrile/ 5% trifluoroacetic acid (2 steps, 20 min at RT each), dried,
resuspended in 0.1% trifluoroacetic acid and purified with micro ZipTip C18
pipette tips (Milllipore, Billerica, MA) eluting directly in the matrix solution (10
mg/ml cyano-4-hydroxycinnamic acid in 50% acetonitrile/1% TFA). The mass
spectra of the tryptic peptides were obtained using a Voyager-DE MALDI-ToF
mass spectrometer (Applied Biosystems). Peptide mass fingerprint database
searching was carried out using the PeptIdent algorithm (http://www.expasy.org)
in the SWISS-PROT and TrEMBL databases, setting the parameters to allow
one missed cleavage and a mass tolerance of 1 Da.
2.6. Analysis of the actin cytoskeleton
Cells (0.8×107 cells/ml) were treated with 50 μM Esc 1–21 in liquid YEPD
and incubated at 30 °C with shaking for 45 min. Treated and untreated cells were
harvested by centrifugation at room temperature. The pellet was washed twice in
water and resuspended in RIPA buffer (50 mM Tris–HCl pH 7.5, 150 mMNaCl,
5 mM EDTA, 1% NP-40, 1 mM PMSF, and 2 μg/ml each of aprotinin, pepstatin
A and leupeptin (Sigma-Aldrich)). Cells were broken with glass beads in a
Fastprep instrument (Savant) and lysates were clarified by centrifugation at
13,000 rpm for 10 min. The protein concentration was determined by BCA
assay (Pierce) and 40 μg of total proteins (per gel lane) from each lysate were
mixed with Laemmli buffer and incubated al 95 °C for 5 min before running on a
12% polyacrylamide gel. After standard SDS-PAGE, proteins were transferred
to a polyvinylidene-difluoride membrane (PVDF by Immobilon P; Millipore,
Bedford, MA) and incubated with anti-actin goat polyclonal antibody (Santa
Cruz Biotechnology, CA) diluted 1:1000 in blocking solution and incubated
overnight at 4 °C. After three washes in phosphate-buffered saline solution with
0.5% Tween-20, the blots were developed using a chemiluminescence detection
system (ECL method by Amersham Biosciences).2.7. Microarray hybridization
The yeast oligonucleotide array was constructed using the S. cerevisiae
Genome Oligo Set ™ (Operon Technologies, CA, USA) composed of 6240
optimized oligonucleotides (70mers) each representing one yeast gene. The
lyophilized oligonucleotides were resuspended in 3× SSC solution and printed
using the microarrayer Omnigrid 100 (Genomic Solutions, Ann Arbor, MI,
USA) on poly-L-lysine glass slides (Erie Scientific Company, Portsmouth, NH,
USA). After printing, microarrays were post-processed following DeRisi’s
laboratory procedure (http://derisilab.ucsf.edu/).
Yeast cells were treated with Esc 1–21 as described. RNA was extracted
from about 3×108 cells using hot acid phenol-chloroform. Nucleic acids were
ethanol precipitated, washed, dried, and resuspended in TE buffer. Yield ranged
from 2 to 3 mg, with a 260 nm/280 nm absorption ratio of 1.8–2.2. mRNAs were
purified using Extraction Kit from Qiagen (Valencia, CA). The microarray
hybridization protocols were optimized from those reported in [28], using the
indirect labeling method. Briefly, the reactive amine derivative of dUTP, 5-(3-
aminoallyl)-2′-deoxyuridine 5′-triphosphate (Sigma) was incorporated into
cDNA using the Superscript II reverse transcriptase (Invitrogen) and oligo dT
(Invitrogen) and random examers (Roche). After synthesis of cDNA (2–3 h at
42 °C), RNAwas hydrolyzed by addition of sodium hydroxide and EDTA to a
final concentration of 100 mM and 10 mM, respectively and incubated at 65 °C
for 10 min. The hydrolysis reaction was neutralized with 1 M HEPES. After
removing free nucleotides by purification and concentration using Microcon-30
microconcentrators, the aminoallyl-labeled samples were coupled to succinimi-
dyl ester of cyanine-3 (Cy3) and cyanine-5 (Cy5) (Amersham) combined with
1 M NaHCO3, pH 9. Coupling took place in the dark at 25 °C for 1 h.
Appropriate Cy3 and Cy5 labeled cDNA samples were purified following
Qiagen Qiaquick PCR Purification Kit instructions. Poly-dA (12–18 mer), 20×
SSC, and HEPES pH 7.0 were added. After the resultant mix was filtered
through a Millipore 0.45 μM filter, 10% SDS was added. The samples were
incubated for 2 min at 100 °C and cooled in a microcentrifuge prior to loading
and then applied to microarray. Incubation took place at 65 °C for 12–15 h.
Hybridized slides were washed in a solution of water, 20× SSC, and 10% SDS,
rinsed in water and 20× SSC, and dried via centrifugation for 2 min at 1000 rpm.
The arrays were scanned immediately. Each comparison was performed in
duplicate.
2.8. Gene expression analysis
Fluorescent cDNA bound to the microarray was detected with a GenePix
4000 microarray scanner (Axon Instruments, Foster City, CA), using the
GenePix 4000 software package to quantify microarray fluorescence. Intensity
values were adjusted by subtracting surrounding background from spots. The
median of spot intensities was corrected for background. To eliminate signals
that are most prone to estimation error, any spot was excluded from analysis if
both the Cy3 and Cy5 mean fluorescence signals were within two standard
deviations of the mean background signals for that spot. This procedure avoids
artificially inflated measurements of expression due to low signals. Additional to
eliminating flagged spots, spots were also visually inspected and flawed ones
discarded from the analysis. Data were normalized to mean ratio intensity. Genes
within each group were examined for functional enrichment using Gene
Ontologies categories (GO) and KEGG metabolic pathways using hypergeo-
metric statistics as implemented in Pathway Processor [21,22]. Functional
annotations of the metabolic pathways were obtained from KEGGhttp://www.
genome.ad.jp/kegg). Mips categories were used to improve yeast classification
data. Yeast deletion data were obtained from (http://mips.gsf.de/projects/fungi/
yeast.html).
3. Results
3.1. Esculentin 1–21 has antifungal activity
To analyze the molecular basis of the effect of Esc 1–21, we
focused on W303-1A, a S. cerevisiae strain well characterized
both at the proteomic and the gene expression level.
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increasing concentrations of peptide (10, 25 and 50 μM). As
shown in Fig. 1 (panel A), 50 μM Esc 1–21 inhibited cell
growth, while 25 μM concentration just slightly decreased the
strain growth rate in liquid medium. As evident from the figure,
the incubation with 25 μM of peptide caused a decrease of only
23% of the growth rate up to 3 h of treatment in comparison to
the control. The cells treated with 50 μM of Esc 1–21 showed a
significant and more prolonged reduction in growth rate of
about 77% up to 6 h of incubation.
The effect of Esc 1–21 on cell viability, measured as the
ability of the cells to give rise to colonies, was tested after the
growth in liquid medium containing various concentrations of
antimicrobial peptide, for different times, as described in
Materials and methods. All cells were still able to form
colonies after 3 h of treatment with 25 μM Esc 1–21 (Fig. 1
panel B). The results indicate that this peptide concentration
induced cell growth arrest instead of cell death. A moreFig.1. Growth inhibition by Esculentin 1–21. (A) Sensitivity of W303-1Ayeast
cells to Esc1–21. Exponentially growing cells were diluted to 0.1×107 cells/ml
in liquid YEPD and treated with different Esc1–21 concentrations for 24 h at
30 °C. Growth rate of treated (● 10 μM,▪ 25 μM, ▴ 50 μM) or untreated (□
0% v/v, ○ 0.4% v/v, ▵ 0.8% v/v of ethanol) cells was determined by OD
measurements at 600 nm for the indicated times. (B) Cell viability. W303-1A
cells were incubated in liquid YEPD cultures with different Esc1–21
concentrations (▪ 25 μM, ▴ 50 μM, ● 100 μM) or ethanol 0.8% v/v as
control (□) for 9 h at 30 °C. Aliquots were removed at time intervals, diluted and
plated on YEPD without peptide for viable cell counts. Values represent the
mean of three determinations±SD.significant effect on growth is obtained when 50 μM Esc 1–21
was used, resulting in almost 30% of cells unable to form
colonies after 3 h of incubation. To investigate whether a
higher concentration of Esc 1–21 induced cell death, the
viability of yeast cell following treatment with 100 μM Esc 1–
21 was evaluated. As shown in Fig. 1 (panel B) the growth
arrest observed was fairly rapid: less than 50% of the cells
were still able to form colonies after 3 h, indicating that in this
condition concentration required for 50% growth inhibition
(IC50) was 100 μM. In any conditions, after 6 h, the effect on
growth inhibition disappeared and the surviving cells restarted
to grow. The cells treated with Esc 1–21 at different times
showed alterated morphology. The cell abnormalities were
mainly wrinkling of the surface.
These features appeared immediately when the cells were
treated with 100 μM of peptide but, as observed in viability
data, after 6 h the surviving cells exhibited morphology
similar to the control (data not shown). We can conclude that
25 μM Esc 1–21 induced reversible cell growth arrest instead
of cell death, while higher concentrations such as 100 μM,
resulted in 50% of cell death. No TUNEL staining was
observed in all the cells, indicating that the phenotypes
observed are not associated with cell death by apoptosis (data
not shown).
3.2. Esculentin 1–21 treatment induces an increase in osmotic
tolerance and a decrease in heat stress resistance
It is well known that osmotic support suppresses the toxicity
of a killer toxin [23] and that osmotic stabilizers suppress cell
wall lysis [24]. Recent studies indicate that an antifungal agent
(Calcofluor) induces an intracellular response related to
osmoregulation causing an increase in intracellular glycerol
concentration and osmotic tolerance. This effect is a conse-
quence of cell wall perturbation [25]. To test whether the growth
arrest and morphology alteration by Esc 1–21 are the
consequence of cell wall damage or defects we evaluated the
osmotic tolerance by pre-incubating early logarithmically
growing cells (0.8×107 cells/ml) in liquid YEPD supplemented
with different concentrations of Esc 1–21 and determined their
osmotic tolerance (as described in Materials and methods) at
different times. Osmotic tolerance is expressed as the
percentage of cells able to grow on YEPD plates without
peptide and supplemented with 0.6 M sorbitol compared to
those growing on YEPD alone. Esc 1–21 pre-treatment induced
osmotic tolerance in a time- and concentration-dependent
fashion in the W303-1A strain, as shown in Fig. 2 (panel A).
The yeast cells pre-treated with 100 μM Esc 1–21, which
induced 50% of cell death, showed high osmotic tolerance; in
fact, after 3 h at this concentration, the basal levels of osmotic
tolerance were about 3fold increased in comparison to the
control cells at the same time (3 h). As evident from the figure,
at 25 or 50 μM of Esc 1–21 concentrations at 3 h of treatment,
the increment in the osmotic tolerance was not seen. These
results indicate that Esc 1–21 pre-treatment triggers hyper-
osmotic shock response although only at the highest concen-
tration tested.
Fig. 2. Osmotic tolerance and heat stress resistance after Esc 1–21 treatment. (A)
Osmotic tolerance of W303-1A logarithmically growing culture in liquid YEPD
with ethanol 0.8% v/v as control (white) or with Esc1–21 25 μM (gray), 50 μM
(hatched) and 100 μM (black) at 0 time and after 3 h of treatment. Osmotic
tolerance is expressed as the percentage of cells able to grow on YEPD agar
supplemented with 0.6 M sorbitol compared to those growing on YEPD agar
and both without peptide. Values represent the mean of three determinations±
SD. (B) Heat stress resistance of W303-1A logarithmically growing culture in
liquid YEPD and in presence of ethanol 0.8% as control (white) or with Esc1–21
25 μM (gray), 50 μM (hatched) and 100 μM (black) at 0 time and after 3 h of
treatment. Heat stress resistance is expressed as described in Materials and
methods and spreading the pre-treated cells on YEPD agar without peptide.
Values represent the mean of three determinations ±SD.
Fig. 3. 2D profiles of protein abundance during Esc 1–21 treatment. A
representative 2DE gel of the yeast cells treated with 50 μM of Esc 1–21 for 45'
(panel B) or 90' (panel C) and untreated (panel A). Green circles represent
proteins increasing or decreasing more than 3fold (quantitative differences) in
figure treated cells. Green circles with numbers represents spots up-regulated in
T1 and T2. Red, Blue and Magenta circles indicate qualitative differences
corresponding to spots present in the control cells in comparison to T1 (Red
circles) or in comparison to T2 (Magenta circles). Blue circles represent spots
present only in the treated cells (T1 and T2) in comparison to the control. Red
circles with capital letters indicates the MS identified proteins indicate the
qualitative differences corresponding to spots disappearing both in T1 and T2.
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inhibit cell growth in budding yeast [26]. In order to investigate
the effect of Esc 1–21, we evaluated the heat shock resistance of
the logarithmically growing cells (0.8×107 cells/ml ) in liquid
YEPD at 30 °C supplemented with different concentrations of
Esc 1–21. As shown in Fig. 2 (panel B), W303-1A cells treated
with 100 μM Esc 1–21 displayed a dramatic decrease in heat
stress resistance in comparison to the control. The yeast cells
pretreated with 25 or 50 μM of peptide showed 75% and 80%
respectively, of cell viability after heat shock.
From the data presented in Fig. 2 (panel A and B), it can be
concluded that pre-treatment of W303-1A cells with 100 μM
Esc 1–21 clearly resulted in an increase of osmotolerance and a
decrease in heat stress resistance, leading us to conclude that,
for this yeast strain, osmotic tolerance and heat stress response
are anti-correlated. These results suggest that Esc 1–21 could
act on yeast cell wall integrity by inducing a response similar to
that elicited from osmotic shock [27].3.3. Comparison of the 2D gel patterns of the treated and
untreated yeast cells and identification of protein variations
Although the molecular details of the yeast growth arrest
under peptide exposure are still unknown and in order to
understand the proteins involved in the response to Esc 1–21,
we investigated the changes in the proteomic pattern. To
characterize this Esc 1–21 response, exponentially growing
cells were treated with 50 μM peptide for 45 and 90 min. These
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above) that 0.8×107 cells treated with 50 μM of peptide for 3 h,
showed a reversible growth inhibition phenotype with about
70% viable cells. Extracts from control and treated cells were
than subjected to comparative two-dimensional gel electrophor-
esis. The analysis were performed in triplicate to determine
whether the relative protein expression changes for Esc 1–21
treatment at 45 (T1) (Fig. 3, panel B) or 90 (T2) min (Fig. 3,
panel C) versus control (Fig. 3, panel A) were statistically
relevant. Significant differences were found between 45 and
90 min of treatment as shown in Fig. 3. The corresponding 2-DE
gels from control at 45 (T1) and 90 (T2) min did not show
differences in the protein expression (data not shown). A total of
134 spots, (108 in T1 and 26 in T2) were changed, and 14 of
these spots were found in common between T1 and T2 of the
treated cells, of which 4 in T1 and 5 in T2 were up-regulated
(panels B and C green circles and numbers); 29 (T1) and 5 (T2)
spots were down-regulated (panels B and C green circles); 25
and 5 (T1 and T2 respectively) spots were present only in the
treated cells (panels B and C blue circles). Fifty in T1 (panel A
red circles) and 11 in T2 (panel A magenta circles and red circles
with capital letters) were totally unexpressed in comparison with
the control. Six spots found in common between gels from T1
and T2 represented proteins which expression was not
detectable on 2D gels from Esc 1–21 treated cells both in T1
and in T2 in comparison to the control. These spots (panel A red
circles and capital letters and Table 2) were identified. For this
study, only unique and deleted expression protein spots in both
T1 and T2 gels, in comparison to the control, were chosen for
MS analysis. Most of these identified proteins were enzymes
involved in the lower part of glycolysis like enolase (spot C),Table 2
Proteomic and transcriptomic results of qualitative differences in treated cells
In the table are listed the MS identified proteins reported in Fig. 3 and the correspo
a SwissProt/TrEMBL accession number.
b Predicted pI and Mr according to protein sequence.
c Score is -log10(P), where P is the probability that the observed match is a random
SwissProt database using MASCOT searching program (Matrix Science, London, U
d,e T1 and T2 are the ratio values of expression measured using DNA microarrays, a
untreated control.alcohol dehydrogenase I (spot B), pyruvate kinase (spot E) and
pyruvate decarboxylase (spot D) , suggesting a lower fermenta-
tive capacity in the Esc 1–21-treated cells, probably due to a
drop-out of total protein expression. We also identified actin,
another protein repressed by Esc 1–21 (Fig. 3 panel A and Table
2 spot A). It is known that there is a correlation between growth
arrest, morphological changes and perturbations of actin
cytoskeleton. The decrease in actin level suggests that Esc 1–
21 affects the integrity of the plasma membrane, resulting in
dramatic changes in cell physiology. To further verify the effect
of drug treatment on actin expression levels we analyzed treated
and untreated cell extracts by Western blot using anti-actin goat
polyclonal antibody. The results are shown in Fig. 4 in which it
is evident that the expression of actin is dramatically repressed
after 45 min of treatment with Esc 1–21 (lane D) in comparison
with time 0 (lane B) or the corresponding controls (lane A, time
0 and lane C, 45 min).
3.4. Expression profiling of yeast cells treated with Esc 1–21
Whole expression analysis with DNA microarrays was used
to further characterize the response to Esc1–21. Expression
analysis was performed on an aliquot of cells processed in
parallel to that used to generate 2D gel patterns. After 45 (T1)
and 90 min (T2) of treatment with 50 μM Esc 1–21 cells were
harvested and the whole genome expression changes were
analyzed through comparative hybridization to oligonucleotide
arrays of mRNA extracted from treated versus untreated cells
[28]. A total of 5240 genes were significantly expressed in the
two experiments (data not shown). Since we were analyzing
our results at the cellular network and pathway level, wending genes.
event; protein scores greater than 50 are significant (pb0.05). It is based on
K; http://www.matrixscience.com).
fter 45 (T1) and 90 min (T2) of treatment with 50 mM Esc 1-21, realtive to the
Fig. 4. Analysis of the actin cytoskeleton. Western blot analysis of an extract of:
W303-1A control strain treated with ethanol 0.8% v/v for 0 or 45 min (lanes A
and C) and W303-1A treated with Esc1- 21 50 μM for 0 or 45 min (lanes B and
D). Expression of actin was detected using anti-actin goat polyclonal antibody as
described in Materials and methods.
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capture a number of connected significant effects (Supple-
mentary Table 1).Table 3
Pathway processor results
List of pathways that are most affected in at least one of the two microarray expe
measure the probability that a pathway is significantly altered, for a threshold of 1.8. T
in each pathway, the total number of ORFs contained in the pathway, and the proportio
indicates the extent of the variation, based on the magnitude of the P-values and the
a This column lists the number of genes in the particular pathway present in the da
b This column lists the number of genes that passed the cutoff in the particular pat
program was run.
c F:ET. Fisher Exact Test (−1.8, 1.8).Only 100 genes are in common between T1 and T2
(Supplementary Table 2). The decrease in number of genes
altered in T2 is in agreement with the proteomic analysis results
and the recovery also observed in terms of growth rate.
We further analyzed the expression profiles of cells in T1
and T2, scoring significant enrichment for functional cate-
gories, as annotated in KEGG, MIPS, GO and BioCYC (see
Materials and methods for details). The significance of calling
the entire class of genes up-regulated was assessed using the
Fisher’s Exact Test, calculated with the hypergeometric
distribution, whereby the genes belonging to each annotated
class were extracted and visualized using an updated version of
the Pathway Processor software (http://:www.ducciocavalieri.
org/pathway%20processor) (Table 3). The pathway-basedriments This Pathway Processor Programm employs the Fisher Exact Test to
he factors taken into account are: the number of ORFs whose expression is altered
n of the ORFs in the genome contained in a given pathway. The color of the cube
sign, with red being up-regulated, green down-regulated, and yellow no change.
ta file.
hway. In parenthesis is listed the fold change range that was entered when the
695T. Gamberi et al. / Biochimica et Biophysica Acta 1774 (2007) 688–700analysis indicates that 8 out of the 21 pathways with p values
less than 0.05 in T1 are involved in cell wall structure, actin
cytoskeleton and spindle body (“cell-wall mutants”, “Other
cell-wall mutants”, “calcofluor white resistance”, secretory
mutants” “spindle mutants”, “other budding mutants”, “bud
localization” and “actin cytoskeleton mutants”). This effect
exists in part, although attenuated, also in T2 (“other cell
morphology mutants”).
As reported by Gasch et al. [14], yeast cells respond to
environmental changes by altering the expression of thousands
of genes, displaying a genomic expression program. The Gasch
program includes features that are specific to each stress, and
features that respond in a stereotypical manner following
environmental stress, referred to as Environmental Stress
Response (ESR). When we clustered the 100 genes in common
at the 1.5fold threshold between T1 and T2 with the Gasch
results (Fig. 5) it became evident that at the transcriptional
level the expression response elicited by Esc 1–21 resembled
the response to osmotic shock induced with sorbitol. In
particular, we found GSY2 (glycogen synthase, YLR258W)
and the phosphoglucomutase PGM2(YMR105C) up-regulated
after 90 min of treatment, as reported after sorbitol osmotic
stress, and ENA2(YDR039C), a gene important for salt
tolerance. We found the GPD1(YDL022W), a glycerol 3P
dehydrogenase involved in the HOG response up-regulated
both in T1 and T2. This fact could justify down-regulation of
the enzymes of the lower part of glycolysis found in the 2D gel
experiments and in the transcriptional analysis (Supplementary
Table 3), suggesting the production of glycerol as an
osmoprotectant. The fact that Esc1–21 long-term response
and adaptation mechanisms involved regulation of cell
membrane structure and permeability is also indicated by the
observation that 48 of the 88 genes showing the same trend in
T1 and T2 are localized to the cellular, endoplasmic,
mitochondrial, or nuclear membranes, and 10 are important
for membrane folding or stability. We found up-regulated
genes involved in trehalose synthesis (TPS1(YBR126C), TPS2
(YDR074W) and TSL1(YML100W)) (Table 4) associated with
osmotic shock. The induction of genes important for resistance
to osmotic stress could prompt the cell to respond to osmotic
stress and explain the tolerance of treated cells to exposure to
0.6 M sorbitol (Fig. 2, panel A). Not only the trehalose genes but
other genes involved in the cold and heat shock response and
sensitivity (Table 4) were differentially expressed upon treat-
ment with Esc1–21. A number of additional cold and heat shock
proteins ( HSP42 (YDR171W), HSP104 (YLL026W), HSP12
(YFL014W), SSE2(YBR169C)), were also up-regulated in T2
with respect to T1. An opposite trend was shown by KAR2
(YJL034W) and other HSPs of the Hsp70s group2, the
expression of which is about 2fold down-regulated in T1
together with 18 other heat response genes, including OLE1
(YGL055W), a gene required for resistance to heat, heavily
repressed in T1 (−2.5fold) and T2 (−4fold). The class of the cell-
wall proteins often expressed upon stress or stationary phase was
significantly affected:CWP1(YKL096W), a member of the SPR
(serine/alanine rich proteins) and important constituent of the
cell-wall, was up-regulated. PSA1(YDL055C), a GDP-mannosepyrophosphorylase required for normal cell-wall structure, was
repressed in T1 and activated in T2.
As shown in Table 4, genes involved in DNA replication,
inheritance, and G1-S transition were also affected in T1
(“Nuclear mutants class”, “G1 arrest”), but not in T2. Nine of the
12 anti-correlated genes between T1 and T2 at the 1.5threshold
(Supplementary Table 3) were important for cell division; one
CLN2(YPL256C), a cyclin that affects G1/S transition of mitotic
cell cycle, was repressed almost 3fold at T1 and slightly
overexpressed at T2 (Table 5). The majority of genes affected by
45 min of Esc 1–21 treatment belonged to carbon metabolism
(Supplementary Table 3). The up-regulated pathways were:
“carbohydrate–lipid biosynthesis defects”, “other carbon auxo-
trophies”, “starch and sucrose metabolism”; the down-regulated
were “one carbon pool by folate”, “TCA cycle”.
4. Discussion
In this study we report the biological effects of Esc 1–21
on S. cerevisiae. The results suggest that exposure of S.
cerevisiae to sub-lethal levels of Esc 1–21 inflicts growth
inhibition in the W303-1A strain. In particular, a 3h treatment
with 50 μM Esc 1–21 induces reversible cell growth arrest: in
fact after 6 h the effect disappears and cells start to grow
again. Moreover, the treated cells show an abnormal morpho-
logy. Our profound knowledge of S. cerevisiae biology and
genomics and the availability of atlases of gene transcription
upon exposure to various stresses make S. cerevisiae an ideal
candidate for investigation of the genomic and proteomic
effects of Esc 1–21.
Comparative proteomic studies reveal that the yeast strain
treated with Esc 1–21 for two different time, has a different
protein expression pattern. Indeed we found both qualitative
and quantitative differences between the treated and untreated
cell line. In particular the 2D gel analysis identifies an early
more dramatic proteomic response after 45 min and an
adaptation to the drug after 90 min of treatment; the same
trend is true for the transcriptional response.
The Esc 1–21 treatment induces expression of important
genes involved in the osmotic shock response, prompting the
cells to resist and adapt to osmotic stress; in fact GPD1
(YDL022W) a glycerol 3P dehydrogenase, which is also
involved in down-regulation of the enzymes of the lower part
of glycolysis, is up-regulated. Moreover, the changes in TCA
cycle highlighted by the expression analysis are in agreement
with the results of the proteomic analysis: the absence of
Adh1p, Eno2p, Pdc1p and Pyk1p proteins agrees with the
down-regulation of the lower part of glycolysis associated
with an overproduction of glycerol. The expression response
elicited by Esc 1–21 resembles the response to osmotic shock
induced with sorbitol. These data are in agreement with the
cluster between the 100 genes involved in Esc 1–21 treatment
and the Gasch results. Moreover, by analyzing the cell
response to heat and osmotic stress, we reveal that treatment
with the peptide at high concentration, induces an increase in
osmotic tolerance and a decrease in heat stress resistance in
comparison to the control. These results suggest, supported by
Fig. 5. Genomic expression program in response to Esc 1–21 treatment. Hierarchial cluster of the hundred genes in common at the 1.5fold threshold between T1 and
T2 with Gasch results (14). The average expression of genes induced in each response is depicted by a red curve, while the average expression of genes repressed in
each response is depicted by a green curve.
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Table 4
Heat shock proteins and cell wall architecture
*T1 and T2 are the ratio values of expression measured using DNA microarrays, after 45 (T1) and 90 min (T2) of treatment with 50 μM Esc 1–21, relative to the
untreated control.
List of genes under/overexpressed commonly in treated for 45 (T1) or 90 (T2) min or untreated W303-1A yeast cells. These genes belong to the heat shock protein
class or are involved in the cell wall synthesis. The average expression of genes induced in each response is depicted by a red curve, while the average expression of
genes repressed in each response is depicted by a green curve.
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Table 5
Cell cycle progression
*T1 and T2 are the ratio values of expression measured using DNA microarrays, after 45 (T1) and 90 min (T2) of treatment with 50 μM Esc 1–21, relative to the
untreated control.
List of genes under- or overexpressed at both time points. These genes are involved in the cell cycle related processes. The average expression of genes induced in
each response is depicted by a red curve, while the average expression of genes repressed in each response is depicted by a green curve.
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wall integrity, triggering some of the responses of hyper-
osmotic shock through the HOG pathway. In agreement with
this, specific members of the heat shock protein class are also
affected. This may account for the increased sensitivity of
W303-1A cells to heat shock. An alternative hypothesis for
the increased sensitivity of pre-treated cells to heat shock
could be that the activation of the HOG pathway results inincreased production of glycerol and thus increased turgor.
Increasing the temperature increases the fluidity of the plasma
membrane. Together, they result in a further decrease in
plasma membrane integrity.
The transient change in expression of treated cells at 45 min
affects a number of genes encoding proteins that respond to
physiological processes associated with DNA metabolism,
chromosome structure and histone metabolism. This picture is
699T. Gamberi et al. / Biochimica et Biophysica Acta 1774 (2007) 688–700consistent with the reversible cell growth arrest caused by drug-
induced defects of cell wall and cell membranes.
Repression of actin synthesis in treated cells is one of the
major results of proteomic analyses and has been confirmed
by Western blot. This result is in agreement with the report
from Ja Choon Koo [9], showing that Pn-AMP1, an
antimicrobial peptide from Pharbitis nil, induces rapid
depolarization of actin cables in S. cerevisiae and Candida
albicans. The absence of actin in the 2D gels could be the
cause of the compensatory overexpression at 45 min of genes
involved in the actomyosin ring, actin cytoskeleton and
spindle body formation, actin patch assembly, as well as seven
other genes responsible for the progression of bud separation.
In our experiments, only in three cases out of 5 were gene
expression data correlated with proteomic results. Nevertheless
it has to be considered that we are not in steady-state
conditions and that changes in the expression level cannot
allow us to appreciate the effects of protein turnover and
degradation. For example, although Act1 protein is absent
after Esc 1–21 treatment, the expression of the ACT1
(YFL039C) gene is not changed. This could be the result of
compensatory effects associated with a direct insult to the
protein actin (degradation, modification). We can conclude
that Esc 1–21 induces membrane perturbation through specific
interaction with negatively charged phospholipids. Previous
reports indicate that a conserved group of cationic antimicro-
bial peptides, plant defensine, exert their antifungal effect by
inducing membrane permeabilization [27]. We conclude that
only a comparative analysis associating gene expression with
proteomic results can provide complete understanding of the
effects of a drug.
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